VAGIFEM

This brand name is authorized in Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug VAGIFEM contains one active pharmaceutical ingredient (API):

1 Estradiol UNII CXY7B3Q98Z - ESTRADIOL HEMIHYDRATE

Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. Read about Estradiol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VAGIFEM Vaginal tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03CA03	Estradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10203B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 542220090000807
Country: CA	Health Products and Food Branch	Identifier(s): 02325462
Country: EE	Ravimiamet	Identifier(s): 1035896, 1380721, 1380732
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 72171
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 098460, 109499
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 180939
Country: HK	Department of Health Drug Office	Identifier(s): 61339
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-793020012
Country: IE	Health Products Regulatory Authority	Identifier(s): 51303
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7196
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1001934, 1034403, 1054621
Country: MT	Medicines Authority	Identifier(s): MA104/00302
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 105023
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14798
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100234019
Country: SG	Health Sciences Authority	Identifier(s): 14877P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699676100408, 8699676100415
Country: US	FDA, National Drug Code	Identifier(s): 0169-5176
Country: ZA	Health Products Regulatory Authority	Identifier(s): 27/21.8.1/0098, 47/21.8.1/0166